Jan 14, 2021
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it will present at the upcoming NobleCon17, scheduled for Jan. 19–20, 2021. The virtual event is Noble Capital Markets’ annual investor conference. GNPX’s presentation will include a company overview and address the company’s recent progress on planned clinical trials focusing on the treatment of non-small cell lung cancer. Genprex president and CEO Rodney Varner will deliver the presentation to participating investors. The Genprex presentation is scheduled for Tuesday, Jan. 19, at 3:45 p.m. EST. A replay of the presentation will be available on the company’s website and in a catalog of all NobleCon17 presentations to be rebroadcast on Channelchek.
To register for the event, visit https://ibn.fm/C5HbI
To view the full press release, visit https://ibn.fm/01koH
About Genprex Inc.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company’s website at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
Demonstrations are expected to continue this weekend in Paris and other French cities. Some museums and tourist sites will be closed, and visitors should expect a strong police presence.
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Visa, a global leader in digital payments and the Singapore Tourism Board (STB) have signed a three-year Memorandum of Understanding (MOU) to strengthen Singapore’s appeal as a preferred travel destination and to unlock new growth opportunities. The collaboration will focus on three key pillars – driving discovery of Singapore’s tourism products, especially its dining and night-time experiences; deriving insights to identify high-value tourism opportunities; and developing co-branded marketing campaigns to build brand preference for both Visa and Singapore.
Melco Resorts & Entertainment’s newest hotel, REM, opened this week to complete the ultra-luxury trio at the City of Dreams in Macau. Rebranded from the Countdown Hotel, which was the Hard Rock Hotel before that, the property sits alongside the Zaha Hadid-designed Morpheus and Asian-inspired Nuwa, positioning itself as the most exclusive of the three. REM stands for rapid eye movement, the phase of sleep during which “we have the most vivid dreams”, said Lawrence Ho Yau-lung, chairman and CEO of...
As a woman in her 50s living in youth-obsessed Los Angeles, I was well aware of my age. Thankfully, my husband still gazes at me with desire and love.
From a floating sauna village to a ballroom restaurant, three local entrepreneurs reveal where to eat, unwind and make connections in Norway’s third city, and why its cooperative spirit makes it so rewarding to work in. The post Is Trondheim the Nordics’ Coolest New Business Stop? Its Tastemakers Think So appeared first on Business Traveller.
From trophy-winning blanc de blancs to rare library releases, WineGB’s Golden 50 has gathered the top-scoring English wines across nine competitions. The post The Golden 50: These are the Best English Wines of 2026 appeared first on Business Traveller.
Lead cast: Yim Si-wan, Seol In-ah, Kim Jung-hyun, Yeonwoo Latest Nielsen rating: 4.7 per cent In the romantic comedy Love in Disguise, Yim Si-wan plays a vain corporate heir suspected of murder who hires a new personal bodyguard, unaware that his protector is actually a female detective in disguise (played by Seol In-ah of Business Proposal). The series marks a return to more conventional K-drama fare for Yim, following his intense roles in the action film Mantis (2025) and the second and third...
Bracing coastal walks, characterful pubs and cosy bookshops - there are plenty of reasons to head to the coast even as autumn draws to a close.
Four years after launching operations in Mexico, Arajet continues to strengthen its presence in this important market, achieving historic performance to date. This is reflected in the growth of total air passenger traffic between the two countries, which, according to data from the Dominican Republic’s Civil Aviation Board (JAC), is projected to exceed 398,000 passengers by the end of 2026. This significant increase in passenger traffic represents 423% growth compared to the 76,049 passengers transported in 2022, the year the Dominican flag carrier began operations in Mexico.
During his performance for “Dedication Night” on Dancing with the Stars, Tyler Cameron revealed that he and his fiancée Tate Madden are expecting their first child together. View this post on Instagram Cameron and his professional partner, Sharna Burgess, were joined on stage by Madden and the trio performed to Ed Sheeran’s “Supermarket Flowers”. After their routine, Cameron and Madden also had a surprise gender reveal on stage – it’s a baby girl! Later, in...
Breakfast at Fred 62, hiking at Griffith Park and a vintage jacket shopping spree are on the agenda for the Emmy-nominated actor.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.